Marshall Wace, LLP Inmune Bio, Inc. Transaction History
Marshall Wace, LLP
- $77.3 Billion
- Q3 2024
A detailed history of Marshall Wace, LLP transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 79,888 shares of INMB stock, worth $365,088. This represents 0.0% of its overall portfolio holdings.
Number of Shares
79,888
Previous 115,916
31.08%
Holding current value
$365,088
Previous $1.02 Million
57.93%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding INMB
# of Institutions
71Shares Held
5.92MCall Options Held
243KPut Options Held
46.4K-
Black Rock Inc. New York, NY813KShares$3.71 Million0.0% of portfolio
-
Praetorian Pr LLC Rincon, PR781KShares$3.57 Million1.64% of portfolio
-
Vanguard Group Inc Valley Forge, PA721KShares$3.29 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$2.73 Million45.87% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL369KShares$1.69 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $82M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...